Poncirin, a natural bitter
flavanone glycoside abundantly present in many species of citrus fruits, has various
biological benefits such as
anti-oxidant, anti-microbial, anti-inflammatory and anti-
cancer activities. The anti-
cancer mechanism of
Poncirin remains elusive to date. In this study, we investigated the anti-
cancer effects of
Poncirin in AGS human
gastric cancer cells (gastric
adenocarcinoma). The results revealed that
Poncirin could inhibit the proliferation of AGS cells in a dose-dependent manner. It was observed
Poncirin induced accumulation of sub-G1
DNA content, apoptotic cell population, apoptotic bodies,
chromatin condensation, and DNA fragmentation in a dose-dependent manner in AGS cells. The expression of
Fas Ligand (FasL)
protein was up-regulated dose dependently in
Poncirin-treated AGS cells Moreover,
Poncirin in AGS cells induced activation of
Caspase-8 and -3, and subsequent cleavage of
poly(ADP-ribose) polymerase (PARP). Inhibitor studies' results confirm that the induction of
caspase-dependent apoptotic cell death in
Poncirin-treated AGS cells was led by the Fas
death receptor. Interestingly,
Poncirin did not show any effect on mitochondrial membrane potential (ΔΨm),
pro-apoptotic proteins (Bax and Bak) and
anti-apoptotic protein (Bcl-xL) in AGS-treated cells followed by no activation in the mitochondrial apoptotic
protein caspase-9. This result suggests that the mitochondrial-mediated pathway is not involved in
Poncirin-induced cell death in
gastric cancer. These findings suggest that
Poncirin has a potential anti-
cancer effect via extrinsic pathway-mediated apoptosis, possibly making it a strong therapeutic agent for human
gastric cancer.